INMT-MINDY4 readthrough (INMT-MINDY4)

INMT-MINDY4 readthrough (also known as INMT-FAM188B readthrough, INMT-FAM188B, INMT-MINDY4) is not a protein-coding gene and not a therapeutic target. It is an RNA gene product classified as a nonsense-mediated mRNA decay (NMD) candidate and not believed to encode a functional protein[2][4][5]. This entity is not a functional protein, enzyme, receptor, transporter, or clinically actionable target, but rather represents a rare transcript event with no known translated product[2][4][5]. INMT-MINDY4 readthrough represents a rare, naturally occurring transcript generated by read-through transcription between the INMT (indolethylamine N-methyltransferase) gene and the FAM188B (Family with sequence similarity 188, member B/MINDY4) gene on chromosome 7[2][4][5]. The resulting RNA is classified as a nonsense-mediated mRNA decay (NMD) candidate, and is unlikely to produce any protein product. This means it does not encode a functional protein and is not considered a druggable or actionable molecular target. There are no known associated functions, disease roles, pharmacological interactions, or biomarker utilities[2][4][5]. In summary, INMT-MINDY4 readthrough is a non-coding, NMD-targeted RNA transcript with no evidence for protein expression or therapeutic relevance as a molecular target.

Other names

INMT-FAM188BINMT-FAM188B readthrough (NMD candidate)INMT-FAM188B readthrough (non-protein coding)INMT-MINDY4

Not applicable (no known targeting drugs)